FDA
approval
· 2026-04-15
FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)
Summary
This is a supplemental FDA approval for DATSCAN (ioflupane I-123) as a dopamine transporter imaging agent. It helps in evaluating suspected Parkinsonian syndrom…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DATSCAN (IOFLUPANE I-123)